Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts

Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination

Hyperthermia today: electric energy, a new opportunity in cancer treatment

Autologous dendritic cells pulsed with eluted peptide as immunotherapy for advanced B-cell malignancies

Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses

Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses

Circulating myeloid dendritic cell directly isolated from patients with chronic myelogenous leukemia are functional and carry the bcr-abl translocation

Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin’s lymphoma and multiple myeloma

Immunization with heat shock protein 105-pulsed dendritic cells leads to tumor rejection in mice

Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses